1. Home
  2. Labeler Index
  3. Lundbeck Pharmaceuticals Italy S.p.a.
  4. 45562-1740
  5. NDC Package Code: 45562-1740-0 Diazoxide

NDC Package 45562-1740-0 Diazoxide

Powder - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
45562-1740-0
Package Description:
10 kg in 1 DRUM
Product Code:
45562-1740
Non-Proprietary Name:
Diazoxide
Substance Name:
Diazoxide
Usage Information:
This medication is used to treat very low blood sugar (hypoglycemia). Certain conditions (such as tumor on the pancreas, cancer, leucine sensitivity) can cause the release of too much insulin. Insulin is a natural substance that lowers blood sugar. This drug works by preventing insulin release from the pancreas, helping to return the blood sugar to normal levels. Diazoxide is a thiazide drug, but has no diuretic ("water pill") effects like other thiazides. Diazoxide should not be used to treat low blood sugar from poor nutrition/diet (functional hypoglycemia).
11-Digit NDC Billing Format:
45562174000
Product Type:
Drug For Further Processing
Labeler Name:
Lundbeck Pharmaceuticals Italy S.p.a.
Dosage Form:
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s):
  • DIAZOXIDE 100 kg/100kg
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    01-26-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 45562-1740-0?

    The NDC Packaged Code 45562-1740-0 is assigned to an UNFINISHED drug package of 10 kg in 1 drum of Diazoxide, drug for further processing labeled by Lundbeck Pharmaceuticals Italy S.p.a.. The product's dosage form is powder and is administered via form.

    Is NDC 45562-1740 included in the NDC Directory?

    Yes, Diazoxide is an UNFINISHED PRODUCT with code 45562-1740 that is active and included in the NDC Directory. The product was first marketed by Lundbeck Pharmaceuticals Italy S.p.a. on January 26, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 45562-1740-0?

    The 11-digit format is 45562174000. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-145562-1740-05-4-245562-1740-00